Evidence map›Paper›PMID 37306904›Full record

ArticleCancer treatment and research2023

Radiation Therapies in Cancer.

Muhammad Rizwan Tariq, Shinawar Waseem Ali, Noor Fatima, Aqsa Jabeen, Asma Saleem Qazi, Amna Hameed, Waseem Safdar

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer treatment and research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Muhammad Rizwan TariqDepartment of Food Sciences, University of the Punjab, Quid-I-Azam Campus, Lahore, Pakistan. Rizwan.foodsciences@pu.edu.pk.
Shinawar Waseem AliDepartment of Food Sciences, University of the Punjab, Quid-I-Azam Campus, Lahore, Pakistan.
Noor FatimaDepartment of Food Sciences, University of the Punjab, Quid-I-Azam Campus, Lahore, Pakistan.
Aqsa JabeenDepartment of Food Sciences, University of the Punjab, Quid-I-Azam Campus, Lahore, Pakistan.
Asma Saleem QaziDepartment of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.
Amna HameedDepartment of Diet and Nutritional Sciences, Ibadat International University, Islamabad, Pakistan.
Waseem SafdarDepartment of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A crucial element of cancer treatment is radiation therapy that is used to destroy tumors and cancer cells through radiation. Another essential component is immunotherapy that helps immune system to combat cancer. The combination of both radiation therapy and immunotherapy is being focused recently for the treatment of many tumors. Chemotherapy includes the use of some chemical agent to control the growth of cancer, whereas irradiation involves the use of radiations of high energy to kill cancer cells. The union of both became the strongest practice in cancer treatment techniques. Specific chemotherapies are combined with radiation in the treatment of cancer after proper preclinical assessment of their effectiveness. Some classes of compounds include platinum-based drugs, antimicrotubules, antimetabolites (5-Fluorouracil, Capecitabine, Gemcitabine, Pemetrexed), topoisomerase I inhibitors, alkylating agents (Temozolomide), and other agents (Mitomycin-C, Hypoxic Sensitizers, Nimorazole).

Indexed as

NeoplasmsGemcitabineHumansImmunotherapyMitomycinNimorazoleGemcitabineMitomycinNimorazole

Identifiers

PMID37306904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.